title: Phosphoethanolamine decoration of Neisseria gonorrhoeae lipid A plays a dual immunostimulatory and protective role during experimental genital tract infection.
abstract: The induction of an intense inflammatory response by Neisseria gonorrhoeae and the persistence of this pathogen in the presence of innate effectors is a fascinating aspect of gonorrhea. Phosphoethanolamine (PEA) decoration of lipid A increases gonococcal resistance to complement-mediated bacteriolysis and cationic antimicrobial peptides (CAMPs), and recently we reported that wild-type N. gonorrhoeae strain FA1090 has a survival advantage relative to a PEA transferase A (lptA) mutant in the human urethral-challenge and murine lower genital tract infection models. Here we tested the immunostimulatory role of this lipid A modification. Purified lipooligosaccharide (LOS) containing lipid A devoid of the PEA modification and an lptA mutant of strain FA19 induced significantly lower levels of NF-κB in human embryonic kidney Toll-like receptor 4 (TLR4) cells and murine embryonic fibroblasts than wild-type LOS of the parent strain. Moreover, vaginal proinflammatory cytokines and chemokines were not elevated in female mice infected with the isogenic lptA mutant, in contrast to mice infected with the wild-type and complemented lptA mutant bacteria. We also demonstrated that lptA mutant bacteria were more susceptible to human and murine cathelicidins due to increased binding by these peptides and that the differential induction of NF-κB by wild-type and unmodified lipid A was more pronounced in the presence of CAMPs. This work demonstrates that PEA decoration of lipid A plays both protective and immunostimulatory roles and that host-derived CAMPs may further reduce the capacity of PEA-deficient lipid A to interact with TLR4 during infection.
authors.affiliation: Department of Microbiology and Immunology, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
authors.forename: Mathanraj
authors.initials: M
authors.lastname: Packiam
authors.forename: Roshan D
authors.initials: RD
authors.lastname: Yedery
authors.forename: Afrin A
authors.initials: AA
authors.lastname: Begum
authors.forename: Russell W
authors.initials: RW
authors.lastname: Carlson
authors.forename: Jhuma
authors.initials: J
authors.lastname: Ganguly
authors.forename: Gregory D
authors.initials: GD
authors.lastname: Sempowski
authors.forename: Melissa S
authors.initials: MS
authors.lastname: Ventevogel
authors.forename: William M
authors.initials: WM
authors.lastname: Shafer
authors.forename: Ann E
authors.initials: AE
authors.lastname: Jerse
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D054804:Cathelicidins / Q000494:pharmacology*; D002461:Cell Line, Transformed; D018925:Chemokines / Q000378:metabolism; D003165:Complement System Proteins / Q000276:immunology; D016207:Cytokines / Q000378:metabolism; D004983:Ethanolamines; D005260:Female; D005347:Fibroblasts / Q000187:drug effects; D006069:Gonorrhea / Q000276:immunology* / Q000378:metabolism; D006801:Humans; D008050:Lipid A / Q000737:chemistry* / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D008826:Microbial Sensitivity Tests; D016328:NF-kappa B / Q000378:metabolism; D009344:Neisseria gonorrhoeae / Q000187:drug effects / Q000235:genetics / Q000276:immunology* / Q000472:pathogenicity; D060737:Reproductive Tract Infections / Q000276:immunology / Q000382:microbiology*; D051197:Toll-Like Receptor 4; D014621:Vagina / Q000378:metabolism
chemical_list: D000900:Anti-Bacterial Agents; D054804:Cathelicidins; D018925:Chemokines; D016207:Cytokines; D004983:Ethanolamines; D008050:Lipid A; D016328:NF-kappa B; C495345:TLR4 protein, human; D051197:Toll-Like Receptor 4; C005448:phosphorylethanolamine; D003165:Complement System Proteins